The Gavi Leap
Transforming the Vaccine Alliance for the future through simplicity, transparency and synergy, paving the way for a ‘Global Health Leap’.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreWhy multidose-vaccine vials could be a game-changer for global RSV prevention
WHO has given its stamp of approval to a multidose formulation of the maternal RSV vaccine for protecting infants. Here’s why it matters.
How Uganda ended its Bundibugyo Ebola outbreak
When laboratory tests confirmed cases of a rare species of the deadly ebolavirus disease in Uganda in May this year, health authorities moved fast to control the spread and save the lives of the infected.
The immediate risk is very low. The discovery shows how warmer weather may change Britain’s defences against mosquito-borne disease.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allPapua New Guinea launches HPV vaccination to protect girls from cervical cancer
Cervical cancer remains one of the leading causes of cancer-related deaths for women in Papua New Guinea, with over 1,000 women diagnosed and ~650 deaths annually.
Global initiative launched to improve access to mpox vaccines
A global initiative to establish a stockpile of mpox vaccines was launched on 27 August, creating a long-term mechanism to ensure countries have access to vaccines when responding to mpox outbreaks.
Gavi commits additional funding for Ebola response
Gavi, the Vaccine Alliance will provide US$ 7 million to fund a shipment of 70,000 doses of the Ervebo vaccine to DRC.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
